Photo by nci from unsplash
Lipid control is a key pillar of secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD). Prior analyses have shown suboptimal use of high intensity statins, even among the highest… Click to show full abstract
Lipid control is a key pillar of secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD). Prior analyses have shown suboptimal use of high intensity statins, even among the highest risk patients with ASCVD (e.g., diabetes, prior MI). We surveyed patients with ASCVD and
Keywords:
atherosclerotic cardiovascular;
challenges cholesterol;
patients atherosclerotic;
cholesterol management;
cardiovascular disease
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!